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Abstract
Introduction The purpose of this study was to investigate the
costs and health status outcomes of intensive care unit (ICU)
admission in patients who present after sudden cardiac arrest
with in-hospital or out-of-hospital cardiopulmonary resuscitation.
Methods Five-year survival, health-related quality of life (Medical
Outcome Survey Short Form-36 questionnaire, SF-36), ICU
costs, hospital costs and post-hospital health care costs per
survivor, costs per life year gained, and costs per quality-
adjusted life year gained of patients admitted to a single ICU
were assessed.
Results One hundred ten of 354 patients (31%) were alive 5
years after hospital discharge. The mean health status index of
5-year survivors was 0.77 (95% confidence interval 0.70 to
0.85). Women rated their health-related quality of life
significantly better than men did (0.87 versus 0.74; P < 0.05).
Costs per hospital discharge survivor were 49,952 €. Including
the costs of post-hospital discharge health care incurred during
their remaining life span, the total costs per life year gained were
10,107 €. Considering 5-year survivors only, the costs per life
year gained were calculated as 9,816 € or 14,487 € per quality-
adjusted life year gained. Including seven patients with severe
neurological sequelae, costs per life year gained in 5-year
survivors increased by 18% to 11,566 €.
Conclusion Patients who leave the hospital following cardiac
arrest without severe neurological disabilities may expect a
reasonable quality of life compared with age- and gender-
matched controls. Quality-adjusted costs for this patient group
appear to be within ranges considered reasonable for other
groups of patients.
Introduction
The annual incidence of sudden cardiac arrest in central
Europe is approximately nine arrests per 10,000 inhabitants
[1]. Thus, more than 600,000 people in Europe may be
affected each year. Since the 1960s, immediate cardiopulmo-
nary resuscitation (CPR) has been considered life-saving for
sudden cardiac arrest [2], and following successful CPR,
patients are routinely admitted to intensive care units (ICUs) to
manage both the causes and acute sequelae. ICUs consume
a large proportion of hospital budgets yet care for a minority ofPage 1 of 9
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within all health care systems, create pressures to ration ICU
care ethically [4]. Restricting the demands for futile medical
services by limiting access to the ICU [5], at least for those
patients likely to die anyway [6], has been proposed as a the-
oretical model to lower expenditures. In patients with sudden
cardiac arrest, ICU and hospital lengths of stay are often pro-
tracted and incurred health care costs are high. Despite high
short-term mortality and significant morbidity [7], long-term
functional capacity for those surviving the initial hospitalization
remains good [8]. Objective cost-outcome studies, integrating
costs and quality-adjusted life years (QALYs) gained, are
required to determine whether ICU admission constitutes a
reasonable use of constrained resources in this patient popu-
lation. To investigate the costs and long-term health status out-
comes after CPR for out-of-hospital or in-hospital cardiac
arrest, we conducted an individual patient-level assessment of
health status at 5 years post-ICU discharge and combined
these outcomes with a fully costed economic evaluation. All
consecutive patients admitted to a single tertiary ICU were eli-
gible for follow-up. We calculated the costs per survivor, costs
per life year gained, and costs per QALY gained. A sensitivity
analysis was conducted to model the impact of changes in util-
ity (life years gained and health status index [HSI]) on the
development of cost-outcome indices.
Materials and methods
Eligibility criteria
The study protocol was approved by the University Hospital of
Aachen (Aachen, Germany) research ethics committee. For-
mal consent prior to contact for patient follow-up was not
required since all patients who were contacted had the
chance to refuse completion of the questionnaire. All patients
admitted to the ICU of Medical Clinic I from 1 January 1999 to
31 December 2001, who received CPR for out-of-hospital or
in-hospital cardiac arrest for any cause, were eligible for study
entry. For the purpose of this study, CPR was defined as at
least one cycle of chest compression and ventilation in
patients with signs and/or symptoms of cardiac arrest. Patient
care was at the discretion of the intensivist in charge without
any explicit standard of care beyond the normal institutional
standards and guidelines. Neither care of the patients nor end-
of-life decision making was influenced by the study protocol at
any time. Demographic data, admission diagnoses, lengths of
ICU and hospital stays, and ICU and hospital mortality rates
were collected prospectively. Severity of illness was classified
using the Simplified Acute Physiology Score II (SAPS II) [9] for
the initial 24 hours after admission to the ICU. The simplified
Therapeutic Intervention Scoring System (TISS-28) [10] and
the Sequential Organ Failure Assessment (SOFA) [11] were
collected daily, and the total maximum SOFA (TMS) was cal-
culated at the end of the ICU stay [12].
Outcome assessment
Health-related quality of life (HRQL) was obtained 5 years
after ICU discharge using a regular mail formal letter, including
a return envelope, containing the validated German interview
form [13] of the Medical Outcome Survey Short Form-36
questionnaire (SF-36) self-report form [14]. In addition, the
questionnaire assessed employment and marital status,
dependency, re-hospitalizations, patients' recollection of their
ICU stay, and their willingness to undergo critical care, if nec-
essary, again. If patients did not respond to the questionnaire
and telephone contact could not be established, the family
doctor and/or relatives of the patients were contacted to pro-
vide the correct address of the patient or to confirm death after
hospital discharge. Patients who could not be contacted, but
were known to be alive, were considered lost to follow-up with
regard to HRQL. Normative HRQL data, including apparently
healthy controls [15] and patients with acute and chronic dis-
eases [16], are available for different age groups of the Ger-
man population. An HSI, which represents overall quality of life
relative to an age-matched reference group, was calculated for
each patient using the SF-36 results. The HSI is a weight rang-
ing from 0 (indifference between life and death) to 1 (perfect
health) and was calculated for each patient as the mean of the
individual domain indices for the eight domains of the SF-36
(that is, by dividing the individual patient result for a particular
domain by the domain mean of the normative data obtained
from apparently healthy Germans [15], summing each domain
index, and dividing by the number of domains). The HSI multi-
plied by life years gained results in QALYs [17]. Patients dis-
charged from the hospital with a Glasgow Coma Scale (GCS)
score of below 6 points (that is, severely neurologically disa-
bled patients) were analyzed separately since formal objective
quality-of-life assessment was not possible.
Costing methodology
The costing methodology in this study is a modification of the
'bottom-up' approach [18,19]. Costs were not limited to index
hospital and ICU admission costs. From the perspective of the
society's health care system, we included post-hospital dis-
charge health care costs and used a 3% annual discount rate
[20]. Other costs to society, such as time lost from work, were
not considered. To consider differences in the complexity of
the individual patient, ICU costs were divided into patient-spe-
cific (variable) and non-patient-specific (fixed) costs. Non-
patient-specific costs were calculated on a patient-day basis,
whereas patient-specific costs were directly attributed to the
individual patient. Labor costs were divided into patient-spe-
cific and non-patient-specific costs. Wages of nurses and phy-
sicians on duty were allocated to patient-specific costs and
distributed according to the patient's TISS-28 score to
account for patient differences in therapeutic activities.
'Backup staff' (that is, vacancies and off-shift) costs were cal-
culated as day-related non-patient-specific costs. The costs
for radiology, clinical chemistry, pathology, and microbiology
were calculated according to the German regulation ofPage 2 of 9
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costs were calculated as a share of hospital costs in relation
to the size of the unit (energy, heating, and maintenance) and
the number of patients and staff (administrative costs).
Cost-outcome descriptions
This study presents both the outcomes and costs associated
with this patient cohort. Cost-outcome descriptions are pre-
sented as costs per survivor, costs per long-term (5 years) sur-
vivor, costs per life year gained, and costs per QALY gained.
To obtain costs per survivor and costs per long-term survivor,
total ICU, hospital, and post-hospital discharge health care
costs were divided by the number of patients who survived
hospital discharge and the number of patients remaining alive
at 5 years post-hospital discharge. Age- and gender-specific
expected annual post-hospital discharge health care costs
were obtained from the German Ministry of Health (that is, for
males: 30 to 44 years, 1,270 € per year; 45 to 64 years, 2,760
€ per year; 65 to 85 years, 5,830 € per year; for females: 30
to 44 years, 1,840 € per year; 45 to 64 years, 3,160 € per
year; 65 to 85 years, 6,250 € per year as of the year 2004
[22]). Post-hospital nursing home costs were estimated for all
patients with a GCS score below 6 points as a monthly aver-
age of 2,700 € (as of the year 2004 [22]). A yearly discount of
3% was subtracted or added for the years before or following
2004, respectively. To estimate the cost per life year gained,
the total costs were divided by the total estimated life years
gained. Life years gained was calculated as the total life years
of follow-up time observed in all patients post-discharge plus
the estimated remaining life span of the patients alive at 5
years. The estimated remaining life span was calculated con-
servatively based on an average age-adjusted life expectancy
of 80.5 years for the male population and 84.3 years for the
female population (for a 65-year-old person as of the year
2002, German Ministry of Health [22]). Cost-utility descrip-
tions were generated via an HSI adjustment of life years
gained. The number of QALYs gained is the product of the
number of life years gained multiplied by HSI. Note that the
HSI could be obtained only for patients surviving at 5-year fol-
low-up; thus, only their life years gained were adjusted. This is
a conservative approach since patients who were discharged
alive, but did not survive to year 5, may have gained quality sur-
vival time.
Statistics
All variables were tested for the assumption of normality using
the Kolmogorov-Smirnov test. Descriptive statistics are
reported as mean and 95% confidence interval (CI), except
when stated otherwise. The Student t test was used for com-
parisons of means of normally distributed data. A non-para-
metric rank test (Mann-Whitney U test) was applied in case of
non-normally distributed data. Categorical data were tested
using the χ2 statistics with Yates correction when appropriate.
Internal consistency of the various domains of the SF-36 was
assessed using the Cronbach's alpha coefficient. A Cron-
bach's alpha exceeding 0.7 is considered to demonstrate
acceptable agreement [23]. In a two-way sensitivity analysis,
both HSI and incremental life years saved for all 5-year survi-
vors who completed the questionnaire were increased and
decreased by 25% and 50%, respectively. Costs were
adjusted considering the changes in post-hospital health care
expenses owing to a longer or shorter remaining life span. All
statistical tests were two-sided, and a significance level (P
value) of less than 0.05 was applied, except when stated oth-




Of 354 patients admitted to the ICU with cardiac arrest, 204
patients (58%) died prior to discharge from the hospital, either
during their ICU stay (n = 171) or later on the ward (n = 26),
not including 7 patients who were discharged with severe dis-
abilities (that is, a GCS score below 6 points). Of the 150
patients (42%) remaining, 40 patients died before year 5, leav-
ing 110 patients (31%) eligible to be surveyed at 5 years.
Twenty patients declined to respond to the HRQL survey at 5-
year follow-up, and 9 patients were known to be alive but were
otherwise lost to follow-up. Eighty-one patients (74% of all 5-
year survivors) completed the entire questionnaire. Complete
demographic information is presented in Table 1. The 29
patients who were unavailable for final follow-up stayed signif-
icantly longer in the ICU and hospital compared with the
cohort completing the questionnaire. Demographic data,
severity of illness on admission (SAPS II), or morbidity (TMS
and TISS-28) did not differ between the two groups. The final
cost-utility description is based on the 81 complete data sets
only (Figure 1). Prior to cardiac arrest, 60 patients (74%) lived
self-supported, a status that was maintained by 56 patients
(68%) 5 years later. The number of patients living in their own
home with some level of support increased from 8 patients
(10%) to 13 patients (16%). After hospital discharge, only a
minority of patients relied on daily custodial support (3
patients, 4%) or lived in nursing homes (6 patients, 5%). Five
years after hospital discharge, 13 (16%) survivors were
employed, 13 (16%) were early retired, and 48 (59%) were
regularly retired due to age. Forty-eight (59%) survivors were
re-hospitalized during the 5-year follow-up (23 survivors once,
5 twice, and 5 three times). Twenty-two (27%) survivors
recalled unpleasant or alarming memories with regard to their
ICU stay. Sixty-nine (85%) reported that they would undergo
intensive care again if necessary. HRQL is displayed in Figure
2. Except pain, emotional role function, and mental health, all
other items were rated somewhat lower than in an age- and
gender-matched population of apparently healthy Germans
[15]. The 81 long-term survivors reached a mean HSI of 0.77
(95% CI 0.70 to 0.85). Women rated their HRQL significantly
better than men did (HSI 0.87 versus 0.74; P < 0.05). There
were no differences in age, severity of illness, ICU and hospital
lengths of stay, or admission diagnosis between men andPage 3 of 9
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and physical role function were rated superior by women (P <
0.05) after 5 years.
Costs
The total ICU costs for all 354 patients with cardiac arrest
amounted to 6,312,700 € (Table 2). The costs for the ward
stay after ICU discharge accounted for 295 € per patient per
day. The total hospital length of stay was 7,544 days. The total
hospital costs, including the ICU stay, amounted to 7,492,771
€. The ICU stay accounted for 84% of total in-hospital costs.
Post-hospital costs of future health care utilization for all 150
patients discharged alive were estimated to be 16,856,851 €,
based on the projected remaining life span of a total 2,409
person-years. For the 110 patients known to be alive at 5
years, costs of future health care utilization after hospital dis-
charge would amount to 15,615,920 €, based on the pro-
jected remaining life span of 2,354 years. The estimated long-
term survival of the seven patients with a GCS score below 6
points, including the incurred ICU, hospital, and post-hospital
costs, is displayed in Table 3. The post-hospital costs of future
health care utilization were estimated to be 1,179,329 €,
based on the projected remaining life span of a total 141 per-
son-years. Including average nursing home costs of 2,700 €
per month, total post-hospital costs would amount to
5,747,729 €. For the 110 patients known to be alive at 5
years, costs of future health care utilization after hospital dis-
charge would amount to 15,615,920 €, based on the pro-
jected remaining life span of 2,354 years.
Costs per survivor and costs per long-term survivor
The costs per hospital survivor were calculated to be 49,952
€ (that is, 7,492,771 € total hospital costs divided by 150 hos-
Table 1
Demographic data, admission diagnosis, severity of illness, and morbidity of all patients admitted to the intensive care unit from 
1999 to 2001 with cardiac arrest (n = 354)




GCS score below 6 points 
(n = 7)
Age in years, mean ± SD 66 ± 13 68 ± 12 61 ± 13 61 ± 12
Median (25th/75th 
percentile)
68 (60/75) 70 (62/77) 61 (53/72) 64 (50/68)
Gender male/female, 
number (percentage)
252/102 (71/29) 148/56 (73/27) 57/24 (70/30) 6/1 (86/14)
ICU stay in days, mean ± SD 
(minimum-maximum)
9 ± 16 (1–113) 8 ± 14 (1–98) 7 ± 11 (1–78) 17 ± 23 (2–67)
Median (25th/75th 
percentile)
3 (1/9) 4 (1/9) 3 (2/7) 6 (2/18)
Hospital stay in days, mean 
± SD (minimum-maximum)
25 ± 28 (1–176) 4 ± 18 (1–150)a 19 ± 18 (1–103) 35 ± 30 (2–101)
Median (25th/75th 
percentile)
15 (5/33) NA 14 (10/22) 26 (15/38)
SAPS II, mean ± SD 47 ± 23 58 ± 19a 38 ± 20 47 ± 21
Median (25th/75th 
percentile)
45 (31/63) 58 (44/71)a 33 (23/53) 53 (24/66)
SAPS II PRM as a 
percentage, mean ± SD
42 ± 33 58 ± 30a 42 ± 33 45 ± 36
Median (25th/75th 
percentile)
35 (12/74) 64 (33/85)a 14 (5/52) 53 (6/78)
Simplified TISS-28 day 1, 
mean ± SD
34 ± 11 36 ± 10 31 ± 8 37 ± 3
Median (25th/75th 
percentile)
34 (28/40) 36 (28/43) 32 (26/37) 37 (34/40)
TMS, mean ± SD 9.6 ± 5.2 11.8 ± 4.5a 6.3 ± 5.0 7.7 ± 5.3
Median (25th/75th 
percentile)
11 (5/13) 13 (10/15)a 5 (2/11) 9 (1/10)
Hospital non-survivors were more severely ill (SAPS II; P < 0.05) and exhibited significantly more organ dysfunctions (TMS; P < 0.05) compared 
with the patients completing the follow-up of 5 years. Age is given as of the day of ICU admission. aSignificant difference between all patients and 
those who survived the hospital stay (P < 0.05). GCS, Glasgow Coma Scale; ICU, intensive care unit; NA, not applicable; PRM, predicted risk of 
mortality; SAPS II, Simplified Acute Physiology Score II; SD, standard deviation; TISS-28, Therapeutic Intervention Scoring System; TMS, total 
maximum Sequential Organ Failure Assessment.Page 4 of 9
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years, initial ICU and hospital costs per long-term survivor
were 68,116 € (that is, 7,492,771 € total hospital costs
divided by 110 5-year survivors).
Costs per life years gained
The 150 hospital discharge survivors were calculated, using
life table methods, to have an estimated total remaining life
span of 16 years per patient (95% CI 14 to 18 years) at the
time of hospital discharge, which provides an additional 2,409
person-years. The estimated age-adjusted post-hospital dis-
charge health care costs for these patients were calculated to
be 6,997 € per person-year. Considering all hospital dis-
charge survivors, the costs per life year gained were 10,107 €
(that is, 7,492,771 € total hospital costs plus 16,856,851 €
post-hospital discharge health care costs divided by 2,409
person-years gained). Including the costs incurred for the
seven severely disabled patients (that is, applying life table
methods to 157 hospital survivors), these costs increased to
11.757 € per life year gained. Considering only long-term sur-
vivors, patients alive at 5 years were calculated to have an esti-
mated total remaining life span of 15 years per patient (95%
CI 13 to 18 years) which, including the 5 years already sur-
Figure 1
From January 1999 to December 2001, a total of 2,806 patients were admitted to the medical int nsive care unit (ICU)
admitted to the medical intensive care unit (ICU). Of those patients, 
354 (13%) had a cardiac arrest with subsequent cardiopulmonary 
resuscitation out of hospital, in hospital, or both and thus qualified for 
study entry.
Figure 2
Medical Outcome Survey Short Form-36 questionnaire (SF-36) of 81 long-term survivors after cardiopulmonary resuscitation
long-term survivors after cardiopulmonary resuscitation. Each scale is 
normalized to a mean of 50, which is considered normal on the basis of 
comparison of SF-36 scores in a general gender- and age-matched 
German control (norm population). The vertical line represents the 
median, and the left and right limits of the boxes represent the quartiles. 
Cronbach's alpha coefficient exceeded 0.7 in all domains, demonstrat-
ing acceptable agreement of the various items.
Table 2
Intensive care unit (ICU) costs incurred for all 354 patients separated into total ICU costs per patient and daily ICU costs per patient
Mean Range 95% confidence interval
Total ICU costs per patient 17,832 € 1,708 to 181,500 € 15,280 to 20,390 €
Daily ICU costs per patient 2,693 € 656 to 5,856 € 2,555 to 2,832 €Page 5 of 9
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years. The age-adjusted post-hospital health care costs for
these patients were calculated to be 6,634 € per remaining
life year for a total of 15,615,920 €. Ignoring life years gained
from patients who died before 5 years post-discharge, the
costs per life year gained for long-term survivors were calcu-
lated as 9,817 € (that is, 7,492,771 € total hospital costs plus
15,615,920 € post-hospital discharge health care costs
divided by 2,354 person-years gained). Again, including the
seven patients with a GCS score below 6 points, costs per life
year gained account for 11,566 €. It is important to present
these long-term survivors separately since they represent the
total sampling frame from which HRQL information could be
obtained at 5 years.
Costs per quality-adjusted life year
Information on HRQL, and thus HSI 5 years after hospital dis-
charge, was available in 81 patients (74% of all 5-year survi-
vors). These 81 patients had an estimated average remaining
life span of 21 years per patient (95% CI 18 to 24 years) for a
total of 1,709 person-years and a calculated average HSI of
0.77 (95% CI 0.70 to 0.85). In this group, total post-hospital
health care costs were 11,572,491 €. Incremental costs per
life year gained thus amounted to 11,156 €. The estimated
remaining life span of 1,709 years multiplied by the HSI of
0.77 translates into 1,316 QALYs, averaging 14,487 € per
QALY gained. A simulation, including the 20 patients who
declined responses to the HRQL survey and the 9 patients
who were lost during follow-up, revealed an estimated total
remaining life span of up to 2,327 life years (average 21 years
per patient, 95% CI 19 to 24 years). Assuming an HSI of 0.75,
which is comparable to those patients who completed the
HRQL questionnaire, an additional 1,766 QALYs would have
been gained. Thus, incremental costs per life year gained for
all 110 5-year survivors would have amounted to 9,931 €, with
13,085 € per QALY gained. Figure 3 illustrates the influence
of changes in utility (life years gained and HSI) and costs for
the 81 patients with completed 5-year HRQL follow-up.
Discussion
Patients who survive cardiac arrest are often considered to
have a grim prognosis and discussion ensues as to whether
they should be universally welcomed to the ICU: costs are
expected to be high and benefits are expected to be moderate
at best. Herein, we present information from a cohort of
patients with HRQL obtained at 5 years following cardiac
arrest and subsequent CPR. We found that HRQL 5 years
after hospital discharge was only slightly lower than age- and
gender-matched apparently healthy German controls. In addi-
tion, both the reported survival (ICU and hospital stays) [24]
and HRQL of our cohort did not differ significantly when com-
pared with publications based on similar patient populations
(in-hospital and out-of-hospital cardiac arrest) [8], other
medical ICU patients [25,26], or ICU patients with sepsis [27].
We followed our patients for 5 years to allow sufficient recov-
ery time before the assessment of health status. This time
frame was selected because the slope of the survival curve
can be expected to proceed in parallel with that of a control
population and it is unlikely that patients' HRQL attributable to
the index hospitalization will improve [25,26,28,29]. These
assumptions permit the prediction of the cohort's remaining
life span based on data from the German Census Bureau and
the calculation of a valid HSI by close approximation. Mean
patient costs per ICU day were twice those obtained for aver-
age ICU patients admitted to the same institution (2,693 €
compared with 1,334 € in less severely ill patients [30]). Con-
sequently, costs per 5-year survivor were also considerably
higher than the average ICU patient (68,116 € versus 14,130
€ [26]). This is attributable to both higher costs per ICU stay
and higher short-term (that is, ICU and hospital) mortality in the
cohort of patients with cardiac arrest; however, the health sta-
tus outcomes and costs per life year saved and per QALY of
our patients compared favorably with general cardiovascular
and pulmonary ICU patient populations from the same ICU
[26]. They also compare favorably with cost-outcome profiles
of a variety of other interventions routinely undertaken in the
critically ill as well as non-ICU patients (Table 4). Our findings
are robust under a wide range of sensitivity analyses adjusting
for patient mortality rates and HSI projected over the esti-
mated remaining life expectancy. In simulation, significant cost
increases per life year gained or per QALY gained were
observed only after the mortality was increased to over 50%
(Figure 3) or by decreasing the HSI below 0.58.
Table 3
Calculated ICU and hospital costs and estimated post-hospital costs incurred for the seven patients with a Glasgow Coma Scale 
score below 6 points
Mean SD Median (interquartile range)
Daily ICU costs per patient 2,285 € 638 € 2,012 € (1,887 €/2,934 €)
Total hospital costs per patient 35,910 € 37,579 € 18,297 € (14,648 €/33,253 €)
Post-hospital costs per patient 132,565 € 59,878 € 122,945 € (91,094 €/186,888 €)
Nursing home costs per patient 654,480 € 362,880 € 534,600 € (405,000 €/988,200 €)
Costs are based on a projected mean of 20 life years gained per patient (median 16.5 years [12.5/30.5]) and a cumulative survival of 141.3 years. 
ICU, intensive care unit; SD, standard deviation.Page 6 of 9
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considered further. First, health care expenditures do not usu-
ally end with hospital discharge, especially for critically ill
patients. In our cohort, the estimated costs incurred for post-
hospital discharge health care services of all 5-year survivors
surpassed their initial ICU and hospital costs by more than
twofold. It is important to point out that, in the absence of spe-
cific data for patients following cardiac arrest, we based these
estimates on average age- and gender-adjusted health care
utilization costs provided by the German Bureau of Census.
Since the majority of the patients in our cohort were readmit-
ted to hospital at least once during the 5-year follow-up, true
long-term health care costs of this patient group may be above
the expected averages reported by the Bureau of Census;
however, there is no reason to expect that they are above the
average that could be expected for other ICU survivors. It is
important to note that we did not consider the potential overall
costs for the society as a whole (earlier retirement, higher
employees' sickness rates, and so on). The compilation of
such data is largely based on estimations and was beyond the
scope of this study. Second, the expected remaining life span
of our 5-year survivors was also based on census data. Since
the best estimates suggest that the hazard of death for survi-
vors of in-hospital arrest parallels the appropriately age- and
gender-matched general population after 2 years [31], it is rea-
sonable to assume that the hazard of death for our patient
cohort parallels the appropriate age- and gender-matched
population. Thus, the application of standard life table (actuar-
ial) methods, using population-based life expectancy tables, is
likely a reasonable approach for estimating remaining life
expectancy. Third, there is a dilemma with patients surviving
hospital discharge with severe neurological deficits (as
defined here with a GCS score of less than 6 points). What is
the quality of life or HSI of such a patient? To the best of our
knowledge, we cannot judge. On a utility scale from zero (rep-
resenting death) to one (representing perfect health), such
patients definitely do not represent one but are most likely not
zero either. We therefore calculated costs of these patients
separately for life years gained but did not include any utility
measures. In these patients, we did not discount life expect-
ancy although one may expect shorter overall survival in this
group [32]. Thus, costs incurred for this subgroup as well as
for the whole population are most likely overestimated. Fourth,
both socioeconomic status and occupational class may affect
patients' perception of quality of life, with patients belonging to
lower status groups reporting a quicker decline in self-
reported health [33]. However, we did not assess socioeco-
nomic status or occupational class of our patients and thus
could not adjust our data. Finally, we should point out that the
Utstein style protocol [34] of basic and advanced life support
was not available in our patient population. Although this
would have been desirable for auditing resuscitation efforts, it
was deemed of secondary interest since our study focused on
outcomes and costs, not quality of care.
Conclusion
Despite some restrictions that emerge owing to the methodo-
logic complexities inherent in any cost-outcome description
conducted in ICU patients [20,35], we found that the costs
per life year and per QALY gained for patients with cardiac
arrest who require ICU admission are reasonable (approxi-
mately 9,930 € and 13,000 €, respectively). Moreover, our
data highlight the somewhat skewed notion that extreme
expenses result from the care of patients who have undergone
basic life support following cardiac arrest. Although it may be
true that patients with cardiac arrest incur considerable costs
Figure 3
Two-way sensitivity analysis depicting costs per quality-adjusted life year (QALY) saved considering both an increase and a decrease in health sta-tus index 5 years post-intensive care unit of 25% and 50%, respectiv ly (bold solid line)
tus index 5 years post-intensive care unit of 25% and 50%, respectively (bold solid line). Moreover, the remaining life years were modelled, again 
considering an increase and a decrease of 25% (fine line) and 50% (dashed line), respectively.Page 7 of 9
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Critical Care    Vol 12 No 4    Graf et al.and resource consumption, the trade-off between input and
output, costs and outcome, justifies such resource allocation,
at least in comparison with other ICU patient groups. We
believe our study is the first to demonstrate that patients who
leave the hospital following cardiac arrest without severe neu-
rological disabilities may expect fair long-term survival and
quality of life for reasonable expenses to the health care
system.
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